Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Got myself another slide this week in small chunks. The PPS is not far from the yearly low.
Looking forward to the upcoming events (preBLA is they even announce it, BLA submittal, Acceptance of BLA, maybe journal publication...). I hope they don't take another year, it's been long enough.
Best of luck with your investments!
Wait, you have not sold yet?? It's pretty easy, put in the order. Done.
Sell the 'many' shares you have. Quick, before it collapses. Hurry up.
Best of luck to Patients, NWBO, and Longs!
Fire at the New Prague Facility
http://ir.cryoport.com/news-releases/2022/01-31-2022-223509366
I had been wondering why the crazy drop for CYRX until I saw this article.
Cryoport partners with Cell Matters to provide cryopreservation services
http://ir.cryoport.com/news-releases/2022/01-27-2022-133147012
Key aspects of the partnership:
Upcoming Milestones
From today's PR:
http://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeutics-provides-corporate-update-and-business
Hi Glider,
I'm not versed in the BO negotiations which may or may not happen (esp. post BLA acceptance). My guess is that OTLK is in a great position to negotiate, i.e. they do not have to sell. They are strongly incentivized (see the SA article), but that's not the only way forward. It may also depend on the interested parties. If a few potential buyers are vying for OTLK, that makes their lives easier.
If a BO occurs though, the return may not be as big as what it could be in 2-3-4 years, but it would be a lot faster. Either way, the percentage of success/great return is high, be it with or without a BO.
I'm just a regular retail investor. I try not to extrapolate too much.
Best of luck with your investments!
Hi Thermo,
I read all your posts since you became 'thermo' (I think you lost an 'o' in some IHub accident :) and posted on 10/27/2016. Lots to learn!
If I may, a couple of questions for you, if that's appropriate.
1) To BO or not to BO: In one post regarding BO (on the NWBO board) when it was a topic at the time (yes, a bit of a manic-depressive board :), you wrote the following steps would :
C Suite BO Incentives
Thanks, VMLG17 for the SA article, lots of good info.
After analyzing some of the CEO COO CFO ... compensation, this is what the author writes:
Bought another OTLK slice, could not resist Mr. Market latest offer :)
Best of luck with your investments!
Hi pgsd,
This is the quote from Lykiri's message:
13 neurosurgeons / London Neurosurgery Partnership
The whole email is big.
This partnership in particular means a bigger 'footprint' to share the info around DCVax internally in the partnership and externally in their respective pratice/hospitals/patients.
I'll echo the sentiment of many longs on this board: You the man!
Best of luck to Patients, NWBO, and Longs!
Consistent timelines, BLA this Quarter!
Thanks pfelgueiras for the updated company presentation, https://ir.outlooktherapeutics.com/static-files/8a3fe36f-d7e7-4453-806b-2ffbfeb502c3, https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167475302
My favorite slide:
Looking forward to the BLA submission PR this quarter.
Best of luck with your investments!
Positive Outlook @ JP Morgan Presentation
1) The acquisition to continue to fuel growth
2) The 2022 outlook
https://ir.criver.com/static-files/f92d7468-bf01-4c5f-9bdb-7015940ab25a
Following the strategy, this looks good medium term/long term.
Best of luck in your investments!
Thanks Reefrad,
They keep executing on their strategy. It takes time but the steps are clear and the manufacturing step is now complete (without FW). It's consistent.
Best of luck to Patients, NWBO, and Longs!
It was a simple question Sushifishman. I'll still say thank you for your opinion, even if your tone is disrespectul. And FYI, i don't post on that other board.
Cheers
What about buy out? What's you take on that.
Cheers!
Cell and Gene Therapy Acquisitions to Enhance End-to-End Offering for Developers
Kissinger and co did not run Theranos 'devices' on patients.
69 doctors who were part of the trial put their names on the 2018 paper.
JRIII is reaching way too much for his own good. His 'argument' looks really dumb. Sad!
Best of luck to Patients, NWBO, and Longs!
That tickled my funny bone!
iclight: The thread started where someone claimed NVCR insiders sold. What did the sell?
The Danish Dude: A VCR.
I'll go with "A gallon of grapefruit juice".
Sawston+TLD+Publication+Conferences
The publication is not tied to the BLA. As a company with the ability to manufacture DCVax-L for compassionate use, a journal publication would reassure patients that indeed this will improve their survival outcome.
Neurosurgeons in the UK (or elsewhere for that matter) pointing to TLD, publication and conferences would be more armed to guide their patients to the very latest against brain cancer.
I very much doubt NWBio will wait for a BLA and a BLA acceptance by the FDA (or the other RAs) to publish the data.
Furthermore:
2022 to be a good year for NWBO.
This year, I expect:
* DCVax-L manufacturing in Sawston
* Journal Article
* TLD
* BLA
Happy New Year and best of luck to Patients, NWBO, and Longs!
Donation Page for Colorado Boulder County Fires
https://www.coloradogives.org/bouldercountywildfirefund
Hundred of homes have been burned to the ground.
https://www.dailycamera.com/2021/12/31/marshall-fire-evacuation-orders-lifted-for-broomfield/
SA article:
$17
Best of luck to Patients, NWBO, and Longs!
Can production for compassionate start with this certification?
Thinking about Dr. Ashkan. I seem to remember that was a possibility.
You are like a chess Grand Master. Thanks for sharing your findings!
Best of luck to Patients, NWBO, and Longs!
SEC Form 4: Shelton Jerrell exercised 65,250 shares at a strike of $2.90 and sold $4,251,176 worth of shares (65,250 units at $65.15) as part of a pre-agreed trading plan
This seems to be the reason for the 8% drop today, as far as I can tell.
Best of luck with your investments!
That was funny. Thanks for the laugh flipper :)
Yes, the Sawston facility should be able to be used for the UK special programs: The MHRA certification is going to be a game-changer.
Best of luck to Patients, NWBO, and Longs!
Thanks MI Dendream,
appreciate your candid reply.
Cheers!
Thanks MI Dendream,
The coming out campaign thread started with the SNO tote bag showing NWBO's logo.
Is this the type of marketing material that unequivocally says "coming out campaign"? I am not familiar with what would constitute this type of material. (It feels 'thin' to me, but again, I'm not familiar with this side).
Thanks MI Dendream!
Best of luck with Patients, NWBO, and Longs!
Got another slice of cheap shares today. I missed the drop below $.8 but still got in cheap at $.87.
Best of luck to Patients, NWBO, and Longs!
Q1 2022 BLA planned: Consistent Timelines
The company keeps to its timeline announced earlier in October.
Do you get answers from CVM?
I wrote an email using the https://cel-sci.com/contact-us/ at Cel-Sci (asking about the pre-BLA meeting status and cGMP on the manufacturing expansion), but no answers.
Do you typically get answers from CVM?
Best of luck with your investments!
Hi Eggplant :)
You write:
Proposed offering.
Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering
NASHVILLE, Tenn., Nov. 8, 2021 /PRNewswire/
Supports 70 Ph 3, 25 MAA or BLAA til EoY 22
582 clinical trials and 8 commercial therapies in regenerative medicine
Note: In August 2021: a record 561 clinical trials, compared with 543 at the end of the first quarter of 2021 and 491 at the end of the second quarter of 2020
Earnings Report Nov. 4th, 2021 highlights:
CRYOPDP: 2021 Europe Bioprocessing Excellence Award from IMAPAC
http://ir.cryoport.com/news-releases/2021/10-29-2021-153029109
CRYOPDP, a Cryoport Company, Receives 2021 Europe Bioprocessing Excellence Award from IMAPAC
Dang, since $2. Nice!! I started around $10, and I am quite happy with the return :))
I'm waiting for the next CC which is planned as of now for Nov. 4th and check their status.
CYRX is executing on growth strategy based on the clinical trials, which feeds eventually into commercial products with much greater revenue, and an expansion strategy with partnering or acquisition for greater territory coverage. It's hard to see them fail, it's just a question of how fast they grow and the EPS turns.
On NWBO, the wait is really long, but with the blended data article I cannot see how the trial with the 'new' endpoints can fail. I believe they have access to funds from different sources, including (very) wealthy individuals who can make sure NWBO does not go BK before top line data/ journal publication. Even if they are really slow, I am betting on positive TLD, journal articles, other news (GMP approval, etc.) to hold up the PPS after TLD, and BLA (in the UK / MHRA first?). It's really long, but I believe it will be quite the return and a positive impact in the fight against cancer (I am in at around $0.27, so already a great return :) ).
Wishing you the best with your investments,
Cheers!